Physician profile
Danny Dvir
NPI 1225311756
$373,805.37
in general payments reported to CMS, 2019-2025
7 companies · $103 in 2025
The $103 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $219K · 2020: $155K · 2021: $109 · 2025: $103.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $103.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $103.42 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $353,300.87 | 2019-2020 | |
| Abbott Laboratories | $10,833.71 | 2019 | |
| Edwards Lifesciences Corporation | $7,858.25 | 2019-2021 | |
| Boston Scientific Corporation | $1,467.84 | 2019 | |
| Jenavalve Technology, INC. | $241.28 | 2019 | |
| Medtronic, INC. | $103.42 | 2025 |
1 company reported research payments only; those appear in the research section below.
Research and ownership
$10,656.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Danny Dvir listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.